ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9698
-0.01%
Brent Oil
82.87
-0.91%
Bitcoin
61,994.30
4.86%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Orgenesis Inc (ORGS)

  7. Orgenesis Inc (ORGS) Noticias

ORGS Orgenesis Inc

0.525
-0.018 (-3.31%)
Última actualización: 14:44:13
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Orgenesis Inc ORGS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.018 -3.31% 0.525 14:44:13
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.547 0.505 0.5796 0.543
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
15/4/202416:07GLOBEOrgenesis Provides Year End Business Update
10/4/202411:00GLOBEGermfree and Orgenesis Announce Asset Purchase and Strategic..
18/3/202407:30GLOBEVered Caplan, CEO of Orgenesis, to Present at the..
13/3/202407:30GLOBEOrgenesis Consortium Awarded €1.5M EUR Grant from the..
04/3/202407:30GLOBEOrgenesis Inc. Announces $2.3 Million Private Placement
29/2/202407:30GLOBEOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon..
31/1/202408:20EDGAR2Form 8-K - Current report
31/1/202408:15GLOBEOrgenesis Acquires Control of Octomera with the Goal of..
24/1/202415:05EDGAR2Form 8-K - Current report
22/1/202415:01EDGAR2Form 8-K - Current report
08/1/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202416:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202405:02EDGAR2Form 8-K - Current report
14/11/202307:30GLOBEOrgenesis Ranked No. 171st Fastest-Growing Company in North..
13/11/202315:15GLOBEOrgenesis Provides Business Update for the Third Quarter of..
09/11/202306:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/11/202308:24EDGAR2Form 8-K - Current report
08/11/202308:00GLOBEOrgenesis Inc. Announces Pricing of $1.1 Million Registered..
02/11/202307:00GLOBEOrgenesis Announces Expanded Partnership Between Octomera..
30/10/202320:30GLOBEOrgenesis Announces Withdrawal of Proposed Public Offering
30/10/202315:07GLOBEOrgenesis Announces Proposed Underwritten Public Offering
21/9/202307:00GLOBECGT Global and Octomera Enter Agreement to Expand Cell &..
06/9/202306:00GLOBECell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard..
05/9/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202306:00GLOBEOrgenesis Provides Business Update for Second Quarter of..
10/8/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:30GLOBEOrgenesis Schedules Second Quarter 2023 Business Update..
13/7/202307:30GLOBEOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief..
12/7/202315:05EDGAR2Form 8-K - Current report
11/7/202306:00GLOBEOrgenesis Announces Name Change of Morgenesis Business Unit..
07/6/202306:00GLOBEOrgenesis and University of California, Davis Sign..
30/5/202308:30GLOBEClaudia Zylberberg Appointed as Independent Board Member of..
22/5/202306:30GLOBEOrgenesis Academy Graduates First Class of Cell and Gene..
19/5/202307:30GLOBEOrgenesis to Participate in Benchmark’s 3rd Annual..
18/5/202306:30GLOBEOrgenesis Announces Collaboration Agreement with SCTbio to..
10/5/202315:30GLOBEOrgenesis Provides Business Update for the First Quarter of..
10/5/202309:00GLOBEOrgenesis Secures an Additional $5 Million Investment from..

Su Consulta Reciente

NASDAQ
ORGS
Orgenesis
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados